Table 3.
Variable | Univariate survival analysis | Multivariate survival analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
Gender (male, female) | 1.651 | 0.739–3.688 | 0.221 | 1.428 | 0.599–3.405 | 0.422 |
Age (≤60, >60) | 0.753 | 0.338–1.680 | 0.489 | 1.374 | 0.601–3.141 | 0.452 |
Smoking (no, yes) | 1.253 | 0.653–1.835 | 0.524 | 1.372 | 0.665–1.732 | 0.536 |
Alcohol use (no, yes) | 1.121 | 0.547–1.538 | 0.753 | 1.231 | 0.557–1.861 | 0.643 |
Tumor size (T1–T2, T3–T4) | 1.331 | 0.528–3.357 | 0.544 | 1.447 | 0.505–4.147 | 0.491 |
Pathological grade (I, II–III) | 1.258 | 0.490–1.994 | 0.117 | 1.246 | 0.444–3.496 | 0.676 |
Cervical nodal metastasis (N0, N+) | 1.759 | 1.240–3.291 | 0.042 | 1.696 | 1.104–3.067 | 0.056 |
Clinical stage (I–II, III–IV) | 1.203 | 0.688–1.824 | 0.095 | 0.922 | 0.524–1.622 | 0.778 |
SUZ12 expression (lowa, high) | 3.023 | 1.216–7.516 | 0.017 | 2.848 | 1.121–7.240 | 0.028 |
The numbers in italic indicate statistical significance with p values <0.05
aBoth of patients with low and negative SUZ12 staining are stratified into low SUZ12 category for simplicity